Program Committee

  • Thomas W. Abrams, RPh, MBA, Director, Office of Prescription Drug Promotion, CDER,FDA 
  • Michelle D. Axelrod, JD, Principal,Porzio, Bromberg & Newman, PC
  • Sara Miron Bloom, JD, Assistant United States Attorney,District of Massachusetts
  • Glenn N. Byrd, MBA, RAC, Senior Director, Promotional Regulatory Affairs,Medimmune Specialty Care
  • Sue Duvall, RN, MPA, Senior Director International Regulatory Advertising and Promotion Abbvie
  • Barri Falk, MS, Director, Life Sciences and Healthcare Strategy,Deloitte Consulting LLP
  • Kim Hasili, BA, MBA, Primary Review Director, Promotional Regulatory Affairs,AstraZenecaPharmaceuticals LP
  • Lynette Hopkinson, PharmD, Senior. Director Commercial Regulatory Affairs,Global Regulatory Affairs,Eisai, Inc
  • Coleen Klasmeier, JD, Global Coordinator, Food, Drug and Medical Device Regulatory Practice,Sidley Austin LLP
  • Joy Liu, Esq, Partner, Ropes and Gray
  • Frank J. Lock, Director, Information Center,Global Commercial Excellence / Global Channel Solutions, AstraZeneca Pharmaceuticals LP
  • Katie Lyons, PharmD, Director,Medical Content Consulting Services
  • Mukesh Mehta, PharmD, MBA, RPh,Vice President, Clinical and Regulatory Solutions,PDR Network, LLC
  • Mark Meltz, JD, Associate General Counsel, Corporate,Biogen Idec
  • Trish Nettleship, Director, Social Media & Influence,UCB, Inc.
  • Ryan Olohan, National Industry Director, Healthcare,Google
  • Leah Palmer, PharmD, Executive Director, Regulatory Promotion,Amgen, Inc
  • Lisa L. Stockbridge, PhD, Branch Chief, Advertising and Promotional Labeling Branch, CBER,FDA
  • Mary Sullivan, Executive Director , Regulatory Affairs, Advertising and Promotion Compliance, Boehringer Ingelheim Pharmaceuticals, Inc
  • Gina Vestea, PharmD, Director, US Regulatory Affairs Marketed Products,Sanofi US Inc
© 2014